Page 349 - IJB-8-4

Mancilla-De-la-Cruz, et al.
J Controlled Release, 66:1–9. Delivery of Domperidone. Sci Rep, 7:2829.
https://doi.org/10.1016/S0168-3659(99)00225-4 https://doi.org/10.1038/s41598-017-03097-x
34. Rowe CW, Katstra WE, Palazzolo RD, et al., 2000, 45. Cader HK, Rance GA, Alexander MR, et al., 2019, Water-
Multimechanism Oral Dosage forms Fabricated by Three based 3D Inkjet Printing of an Oral Pharmaceutical Dosage
Dimensional Printing. J Controlled Release, 66:11–7. form. Int J Pharm, 564:359–68.
https://doi.org/10.1016/S0168-3659(99)00224-2 https://doi.org/10.1016/j.ijpharm.2019.04.026
35. Groll J, Burdick J, Cho D, et al., 2018, A Definition of Bioinks 46. Clark E, Alexander M, Irvine D, et al., 2017, 3D Printing of
and their Distinction from Biomaterials Inks. Biofabrication, Tablets using Inkjet with UV Photoinitiation. Int J Pharm,
11:013001. 529:523–30.
36. Hsu H, Harris M, Toth S, et al., 2015, Drop Printing of https://doi.org/10.1016/j.ijpharm.2017.06.085
Pharmaceuticals: Effect of Molecular Weight on PEG Coated- 47. Lee K, Kang A, Delfino JJ, et al., 2003, Evaluation of Critical
naproxen/PEG 3350 Solid Dispersions. AIChE J, 61:4502–8. Formulation Factors in the Development of a Rapidly
https://doi.org/10.1002/aic.14979 Dispersing Captopril Oral Dosage Form. Drug Dev Ind
37. Kyobula M, Adedeji A, Alexander MR, et al., (2017), 3D Pharm, 29:967–79.
Inkjet Printing of Tablets Exploiting Bespoke Complex https://doi.org/10.1081/DDC-120025454
Geometries for Controlled and Tuneable Drug Release. 48. Yu D, Shen X, Branford-White C, et al., 2009, Novel Oral
J Controlled Release, 261:207–15. Fast-disintegrating Drug Delivery Devices with Predefined
https://doi.org/10.1016/j.jconrel.2017.06.025 Inner Structure Fabricated by Three-dimensional Printing.
38. Alhijjaj M, Belton P, Qi S, 2016, An Investigation into J Pharm Pharmacol, 61:323–9.
the use of Polymer Blends to Improve the Printability of https://doi.org/10.1211/jpp.61.03.0006
and Regulate Drug Release from Pharmaceutical Solid 49. Jacob J, Coyle N, West TG, et al., 2014, Aprecia
Dispersions Prepared Via Fused Deposition Modeling (FDM) Pharmaceuticals LLC. Rapid Disperse Dosage form
3D Printing. Eur J Pharm Biopharm, 108:111–25. Containing Levetiracetam. US9339489B2, Abstract.
https://doi.org/10.1016/j.ejpb.2016.08.016 50. Yu DG, Branford-White C, Ma ZH, et al., 2009, Novel Drug
39. Arafat B, Wojsz M, Isreb A, et al., 2018, Tablet Fragmentation Delivery Devices for Providing Linear Release Profiles
without a Disintegrant: A Novel Design Approach for Fabricated by 3DP. Int J Pharm, 370:160–6.
Accelerating Disintegration and Drug Release from 3D https://doi.org/10.1016/j.ijpharm.2008.12.008
Printed Cellulosic Tablets. Eur J Pharm Sci, 118:191–9. 51. Yu DG, Yang X, Huang W, et al., 2007, Tablets with Material
https://doi.org/10.1016/j.ejps.2018.03.019 Gradients Fabricated by Three-dimensional Printing. J Pharm
40. Sadia M, Arafat B, Ahmed W, et al., 2018, Channelled Tablets: Sci, 96:2446–56.
An Innovative Approach to Accelerating Drug Release from https://doi.org/10.1002/jps.20864
3D Printed Tablets. J Controlled Release, 269:355–63. 52. Pietrzak K, Isreb A, Alhnan M, 2015, A Flexible-dose
https://doi.org/10.1016/j.jconrel.2017.11.022 Dispenser for Immediate and Extended Release 3D Printed
41. Goyanes A, Buanz AB, Hatton GB, et al., 2015, 3D Printing Tablets. Eur J Pharm Biopharm, 96:380–7.
of Modified-release Aminosalicylate (4-ASA and 5-ASA) https://doi.org/10.1016/j.ejpb.2015.07.027
Tablets. Eur J Pharm Biopharm, 89:157–62. 53. Skowyra J, Pietrzak K, Alhnan MA, 2015, Fabrication of
https://doi.org/10.1016/j.ejpb.2014.12.003 Extended-release patient-Tailored Prednisolone Tablets via
42. Goyanes A, Chang H, Sedough D, et al., 2015, Fabrication Fused Deposition Modelling (FDM) 3D Printing. Eur J
of Controlled-release Budesonide Tablets via Desktop (FDM) Pharm Sci, 68:11–7.
3D Printing. Int J Pharm, 496:414–20. https://doi.org/10.1016/j.ejps.2014.11.009
https://doi.org/10.1016/j.ijpharm.2015.10.039 54. Gioumouxouzis C, Katsamenis O, Bouropoulos N, et al.,
43. Li Q, Guan X, Cui M, et al., 2018, Preparation and 2017, 3D Printed Oral Solid Dosage forms Containing
Investigation of Novel Gastro-Floating Tablets with 3D Hydrochlorothiazide for Controlled Drug Delivery. J Drug
Extrusion-based Printing. Int J Pharm, 535:325–32. Deliv Sci Technol, 40:164–71.
https://doi.org/10.1016/j.ijpharm.2017.10.037 https://doi.org/10.1016/j.jddst.2017.06.008
44. Chai X, Chai H, Wang X, et al., 2017, Fused Deposition 55. Boetker J, Water JJ, Aho J, et al., 2016, Modifying Release
Modeling (FDM) 3D Printed Tablets for Intragastric Floating Characteristics from 3D Printed Drug-eluting Products. Eur J

International Journal of Bioprinting (2022)–Volume 8, Issue 4 341